The Cigna Group with ticker code (CI) have now 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $405.00 and $323.00 suggesting an average analyst share price target price of $362.31. (at the time of writing). Given that the stocks previous close was at $301.02 this indicates there is a potential upside of 20.4%. The 50 day moving average now sits at $287.57 and the 200 moving average now moves to $325.62. The market cap for the company is 85.19B. The price for the stock stands currently at: $311.15 USD
The potential market cap would be $102,533,376,976 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 25.65, revenue per share of $872.55 and a 3.93% return on assets.
The Cigna Group is a global health services company. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.
